Efficient Isothermal Titration Calorimetry Technique Identifies Direct Interaction of Small Molecule Inhibitors with the Target Protein

被引:11
|
作者
Gal, Maayan [1 ]
Bloch, Itai [1 ]
Shechter, Nelia [1 ]
Romanenko, Olga [1 ]
Shir, Ofer M. [1 ]
机构
[1] Migal Galilee Res Ctr, Kyriat Shmona, Israel
关键词
Drug screening; fluorescence polarization (FP); isothermal titration calorimetry (ITC); nuclear magnetic resonance spectroscopy (NMR); protein-protein interactions; DRUG DISCOVERY; HIGH-THROUGHPUT; CONFORMATIONAL COVERAGE; FLEXIBILITY; DOCKING; BINDING; VALIDATION; BIOLOGY;
D O I
10.2174/1386207319666151203001529
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Protein-protein interactions (PPI) play a critical role in regulating many cellular processes. Finding novel PPI inhibitors that interfere with specific binding of two proteins is considered a great challenge, mainly due to the complexity involved in characterizing multi-molecular systems and limited understanding of the physical principles governing PPIs. Here we show that the combination of virtual screening techniques, which are capable of filtering a large library of potential small molecule inhibitors, and a unique secondary screening by isothermal titration calorimetry, a label-free method capable of observing direct interactions, is an efficient tool for finding such an inhibitor. In this study we applied this strategy in a search for a small molecule capable of interfering with the interaction of the tumor-suppressor p53 and the E3-ligase MDM2. We virtually screened a library of 15 million small molecules that were filtered to a final set of 80 virtual hits. Our in vitro experimental assay, designed to validate the activity of mixtures of compounds by isothermal titration calorimetry, was used to identify an active molecule against MDM2. At the end of the process the small molecule (4S, 7R)-4-(4-chlorophenyl)-5-hydroxy-2,7-dimethyl-N-(6-methylpyridin-2-yl)-4,6,7,8 tetrahydrIoquinoline-3-carboxamide was found to bind MDM2 with a dissociation constant of similar to 2 mu M. Following the identification of this single bioactive compound, spectroscopic measurements were used to further characterize the interaction of the small molecule with the target protein. 2D NMR spectroscopy was used to map the binding region of the small molecule, and fluorescence polarization measurement confirmed that it indeed competes with p53.
引用
收藏
页码:4 / 13
页数:10
相关论文
共 43 条
  • [21] In silico identification of small molecule protein-protein interaction inhibitors: targeting hotspot regions at the interface of MXRA8 and CHIKV envelope protein
    Verma, Jyoti
    Subbarao, Naidu
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (08) : 3349 - 3367
  • [22] Determination of Amino Acid Residues Responsible for Specific Interaction of Protein Kinases with Small Molecule Inhibitors
    Karasev, D. A.
    Veselovsky, A. V.
    Lagunin, A. A.
    Filimonov, D. A.
    Sobolev, B. N.
    MOLECULAR BIOLOGY, 2018, 52 (03) : 478 - 487
  • [23] Small-Molecule Inhibitors of the CD40-CD40L Costimulatory Protein-Protein Interaction
    Chen, Jinshui
    Song, Yun
    Bojadzic, Damir
    Tamayo-Garcia, Alejandro
    Landin, Ana Marie
    Blomberg, Bonnie B.
    Buchwald, Peter
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (21) : 8906 - 8922
  • [24] Discovery of Novel Small-Molecule Inhibitors Disrupting the MTDH-SND1 Protein-Protein Interaction
    Shen, Hao
    Ding, Jiayu
    Ji, Jiaying
    Hu, Lingrong
    Min, Wenjian
    Hou, Yi
    Wang, Dawei
    Chen, Yuanyuan
    Wang, Liping
    Zhu, Yasheng
    Wang, Xiao
    Yang, Peng
    JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (02) : 1844 - 1862
  • [25] From Determinants of RUNX1/ETO Tetramerization to Small-Molecule Protein-Protein Interaction Inhibitors Targeting Acute Myeloid Leukemia
    Metz, Alexander
    Schanda, Julia
    Grez, Manuel
    Wichmann, Christian
    Gohlke, Holger
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2013, 53 (09) : 2197 - 2202
  • [26] Small Molecule Inhibitors of ERCC1-XPF Protein-Protein Interaction Synergize Alkylating Agents in Cancer Cells
    Jordheim, Lars Petter
    Barakat, Khaled H.
    Heinrich-Balard, Laurence
    Matera, Eva-Laure
    Cros-Perrial, Emeline
    Bouledrak, Karima
    El Sabeh, Rana
    Perez-Pineiro, Rolando
    Wishart, David S.
    Cohen, Richard
    Tuszynski, Jack
    Dumontet, Charles
    MOLECULAR PHARMACOLOGY, 2013, 84 (01) : 12 - 24
  • [27] Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells
    Grinshtein, Natalie
    Rioseco, Constanza C.
    Marcellus, Richard
    Uehling, David
    Aman, Ahmed
    Lun, Xueqing
    Muto, Osamu
    Podmore, Lauren
    Lever, Jake
    Shen, Yaoqing
    Blough, Michael D.
    Cairncross, Greg J.
    Robbins, Stephen M.
    Jones, Steven J.
    Marra, Marco A.
    Al-Awar, Rima
    Senger, Donna L.
    Kaplan, David R.
    ONCOTARGET, 2016, 7 (37) : 59360 - 59376
  • [28] Preparation of Small-Molecule Microarrays by trans-Cyclooctene Tetrazine Ligation and Their Application in the High-Throughput Screening of Protein-Protein Interaction Inhibitors of Bromodomains
    Zhang, Chong-Jing
    Tan, Chelsea Y. J.
    Ge, Jingyan
    Na, Zhenkun
    Chen, Grace Y. J.
    Uttamchandani, Mahesh
    Sun, Hongyan
    Yao, Shao Q.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2013, 52 (52) : 14060 - 14064
  • [29] Structure-Based Optimization of Small-Molecule Inhibitors for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction
    Zhang, Min
    Wang, Zhen
    Zhang, Yongqiang
    Guo, Wenxing
    Ji, Haitao
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (07) : 2989 - 3007
  • [30] Targeting Multiple Conformations Leads to Small Molecule Inhibitors of the uPAR.uPA Protein-Protein Interaction That Block Cancer Cell Invasion
    Khanna, May
    Wang, Fang
    Jo, Inha
    Knabe, W. Eric
    Wilson, Sarah M.
    Li, Liwei
    Bum-Erdene, Khuchtumur
    Li, Jing
    Sledge, George W., Jr.
    Khanna, Rajesh
    Meroueh, Samy O.
    ACS CHEMICAL BIOLOGY, 2011, 6 (11) : 1232 - 1243